EMB vs XBI
iShares JP Morgan USD Emerging Markets Bond ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.39% for EMB.
- • EMB pays a higher dividend yield (5.06%).
Side-by-side metrics
| Metric | EMB | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.39% | 0.35% |
Dividend yield Trailing 12-month yield. | 5.06% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $14.51B | $8.30B |
YTD return | 1.76% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.06 | 1.09 |
P/E ratio | — | — |
Last price | $95.90 | $133.66 |
Inception | — | — |
Issuer | iShares | State Street |
EMB top holdings
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 0.90% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About EMB
EMB (iShares JP Morgan USD Emerging Markets Bond ETF) is USD-denominated emerging market government bonds. Managed by iShares, the fund carries $14.5B in assets under management, an expense ratio of 0.39%, a dividend yield of 5.06%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 0.9% of the portfolio.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.